This systematic review and meta-analysis assessed the impact of physical activity on individuals with Sjögren's syndrome. The analysis included 277 participants randomized to physical activity interventions or control groups. Secondary outcomes encompassed cardiopulmonary function, functional capacity, general health status, vitality, mental health, pain, social aspects, fatigue, and the EULAR Sjögren's Syndrome Disease Activity Index.
Significant improvements were observed for cardiopulmonary function (SMD 0.59, 95% CI 0.20 to 0.99), functional capacity (SMD 0.69, 95% CI 0.33 to 1.05), general health status (SMD 0.46, 95% CI 0.15 to 0.76), vitality (SMD 0.51, 95% CI 0.15 to 0.86), and mental health (SMD 0.42, 95% CI 0.13 to 0.72). These findings suggest a positive association between physical activity and these specific health domains in this population.
Conversely, no significant improvements were detected for pain, social aspects, fatigue, or the EULAR Sjögren's Syndrome Disease Activity Index. The study design limits causal inference regarding disease-modifying effects on fatigue or pain specifically. Given the heterogeneity of interventions and the observational nature of some secondary outcome associations, these results should be interpreted with caution when applying them to individual patient care.
View Original Abstract ↓
Individuals with Sjögren's syndrome (SjD) experience notable health challenges, including chronic pain, fatigue, and depression; however, the potential benefits of physical activity in alleviating these issues remain unclear. We aim to systematically assess the comprehensive effects of physical activity on individuals with SjD.
A comprehensive literature search was conducted in Medline, Embase, Scopus, Web of Science, Cochrane Library, SPORTDiscus, and ClinicalTrials.gov for studies published from inception to November 2025. Two independent reviewers screened the search results and extracted the data. Effect sizes were calculated as the standardized mean difference (SMDs) with 95% confidence intervals (CIs) using random-effects models. Methodological quality was assessed using the Cochrane Collaboration Risk of Bias Tool 2.0, and the certainty of evidence was evaluated with the GRADEpro online tool. Sensitivity, subgroup, and regression analyses were performed to explore potential sources of heterogeneity.
This analysis included six studies with a total of 277 participants with SjD. Compared to controls, physical activity interventions significantly improved cardiopulmonary function (SMD 0.59 [95% CI 0.20 to 0.99]), functional capacity (SMD 0.69 [95% CI 0.33 to 1.05]), general health status (SMD 0.46 [95% CI 0.15 to 0.76]), vitality (SMD 0.51 [95% CI 0.15 to 0.86]), and mental health (SMD 0.42 [95% CI 0.13 to 0.72]). However, no significant improvements were observed in pain, social aspects, fatigue, and the EULAR Sjögren's Syndrome Disease Activity Index.
The results highlight aerobic and resistance training are regarded as effective and practical exercise options.
https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024513141.